PureTech Health plc
Status: Publicly traded
Direct answer
PureTech Health plc is publicly traded on LSE under the ticker PRTC.L.
PureTech Health plc, a biopharmaceutical company established in Boston, Massachusetts, in 2015, functions as a clinical-stage firm primarily within the United States. It is dedicated to discovering, developing, and bringing to market medical treatments for a wide range of severe conditions, including inflammatory, fibrotic, and immunological diseases, challenging cancers, lymphatic and gastrointestinal disorders,...
Can you invest in PureTech Health plc?
Yes. PureTech Health plc trades publicly on LSE as PRTC.L.
View deeper analysis
View detailed research on MarketSnap, including financials, valuation tools, and analyst context.
Open research for PureTech Health plc
Detailed equity research is provided by MarketSnap.